Class II · Moderate risk
Levothyroxine Sodium Tablets
Subpotent Drug
Is Levothyroxine recalled?
Yes — there is an active recall. 62 ongoing FDA recalls mention Levothyroxine (186 total). Check the affected lots below.
Recalls are matched by product description. A recall usually affects specific lots, not every package of Levothyroxine. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.
Levothyroxine recalls on record
none so far in 2026; 186 on record, newest first
Class II · Moderate risk
Levothyroxine Sodium Tablets USP 150 mcg
Subpotent Drug
Class II · Moderate risk
Levothyroxine Sodium Tablets
Product Mix-Up: A single bottle of this lot was reported by a pharmacy to contain 88 mcg tablets instead of 150 mcg tablets.
Class II · Moderate risk
Levothyroxine Sodium Tablets
Subpotent: During long term stability testing of Levothyroxine Sodium Tablets USP for 88 mcg, the assay content was observed below the approved specification range.
Class II · Moderate risk
Levoxyl (levothyroxine sodium tablets, USP)
Subpotent drug
Class II · Moderate risk
Levothyroxine Sodium Tablets
Subpotent Drug: Assay below the approved specification
Class II · Moderate risk
Levothyroxine Sodium Tablets
Subpotent Drug: Assay below the approved specification
Class II · Moderate risk
Levothyroxine Sodium Tablets
Subpotent Drug: Assay below the approved specification
Class II · Moderate risk
Levothyroxine Sodium Tablets
Subpotent Drug: Assay below the approved specification
Class II · Moderate risk
Levothyroxine Sodium Tablets
Subpotent Drug: Assay below the approved specification
Class II · Moderate risk
Levothyroxine Sodium Tablets
Subpotent Drug: Assay below the approved specification
Class II · Moderate risk
Levothyroxine Sodium Tablets
Subpotent Drug: Assay below the approved specification
Class III · Low risk
Levothyroxine Sodium Tablets
Presence of a foreign substance: black hair found embedded in tablet.
Class II · Moderate risk
Levothyroxine Sodium Tablets
Subpotent
Class II · Moderate risk
Levothyroxine Sodium Tablets
Subpotent
Class II · Moderate risk
Levothyroxine Sodium Tablets
Subpotent
Class II · Moderate risk
Levothyroxine Sodium Tablets
Subpotent
Class II · Moderate risk
Levothyroxine Sodium Tablets
Super-Potent Drug: Out of specification potency results were obtained.
Class II · Moderate risk
Levothyroxine Sodium Tablets
Super-Potent Drug: Out of specification potency results were obtained.
Class II · Moderate risk
Levothyroxine Sodium Tablets
Failed Impurities/Degradation Specifications: Out of specifications result observed in the drug substance for impurity test during 3-month long term stability study.
Class II · Moderate risk
Levothyroxine Sodium Tablets
Subpotent and Superpotent Drug
Class II · Moderate risk
Levothyroxine Sodium Tablets
Subpotent and Superpotent Drug
Class II · Moderate risk
Levothyroxine Sodium Tablets
Subpotent and Superpotent Drug
Class II · Moderate risk
Levothyroxine Sodium Tablets
Subpotent and Superpotent Drug
Class II · Moderate risk
Levothyroxine Sodium Tablets
Subpotent and Superpotent Drug
Free recall alerts
Know the day your medication is recalled
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.